MIRA INFORM REPORT

 

 

Report Date :           

22.08.2011

 

IDENTIFICATION DETAILS

 

Name :

ARAB CENTER FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES CO (ACPC)

 

 

Registered Office :

King Abdullah II Industrial City, Sahab, P O Box   22, Amman 11512

 

 

Country :

Jordan

 

 

Financials (as on) :

2010

 

 

Date of Incorporation :

05.06.1983

 

 

Com. Reg. No.:

185, Amman

 

 

Legal Form :

Public Shareholding Company

 

 

Line of Business :

Manufacture of gelatine capsules, pharmaceuticals, medicines and veterinary drugs

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 200,000

Status :

Satisfactory

Payment Behaviour :

Usually Correct 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2011

 

Country Name

Previous Rating

                   (31.12.2010)                  

Current Rating

(31.03.2011)

Jordan

b1

b1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 Bottom of Form

SUMMARY

 

Company Name                                     : ARAB CENTER FOR PHARMACEUTICALS & CHEMICAL

INDUSTRIES CO (ACPC)

Country of Origin                                    : Jordan

Legal Form                                            : Public Shareholding Company

Registration Date                                   : 5th June 1983

Commercial Registration Number                        : 185, Amman

Issued Capital                                        : JD 5,000,000

Paid up Capital                                      : JD 5,000,000

Total Workforce                                     : 120

Activities                                               : Manufacture of gelatine capsules, pharmaceuticals, medicines and

                                                              veterinary drugs.

Financial Condition                                 : Fair

Payments                                             : Nothing detrimental uncovered

Operating Trend                                     : Steady

Recommended Credit Limit                     : US$ 200,000

 

COMPANY NAME

 

ARAB CENTER FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES CO (ACPC)

 

 

company ADDRESS

 

Registered & Physical Address

Location            : King Abdullah II Industrial City, Sahab

PO Box             : 22

Town                 : Amman 11512

Country             : Jordan

Telephone         : (962-6) 4022470 / 4022471

Facsimile          : (962-6) 4022473

Email                : info@acpc.com.jo

 

Premises

Subject operates from a large suite of offices and a factory that are owned and located in the Industrial Area of Amman.

 

 

KEY PRINCIPALS

 

     Name                                                                                              Position

 

·       Mazen Hamza Ahmed Yousef Tantash                                                Chairman

 

·       Atta Al Nazer                                                                                    Managing Director

 

·       Ibrahim To’meh                                                                                 Director

 

·       Meshal Abu Amirah                                                                           Director

 

·       Hamad Tantash                                                                                 Director

 

·       Sami Ziab Abdulla                                                                             Director

 

·       Khalil Nasr                                                                                        Director

 

·       Mohamed Al Ghoul                                                                            Director

 

·       Saadi Qatawi                                                                                    Director

 

·       Mohamed Al Manfaloti                                                                       General Manager

 

·       Dr Ali Musmar                                                                                   Commercial Manager

 

·       Jalal Hatamala                                                                                  Finance Manager

 

·       Yassir Al Nowihy                                                                               Production Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 5th June 1983

 

Legal Form                  : Public Shareholding Company

 

Commercial Reg. No.  : 185, Amman

 

Chamber Member No. : 1229

 

National ID No.            : 200002076

 

Issued Capital              : JD 5,000,000

 

Paid up Capital            : JD 5,000,000

 

Name of Shareholder (s)                                                                                  Percentage

 

·       Hamza Ahmed Yousef Tantash                                                                      44.998%

 

·       General Company For Pharmaceutical Industries & Medical Products                17.500%

     Iraq

 

·       General Corporation For Social Security                                                            4.260%

Jordan

 

·       Jordanian Islamic Bank                                                                                    4.065%

Jordan

 

·       Financial Services Investment Co                                                                      2.534%

Jordan

 

·       Orphanage Financial Investment Corp                                                   2.000%

     Jordan

 

·       Ahmed Hamza Ahmed Yousef Tantash                                                             1.200%

 

·       Mazen Hamza Ahmed Yousef Tantash                                                              1.200%

 

·       Mayser Hamza Ahmed Yousef Tantash                                                             1.200%

 

·       Ms Badour Hamza Ahmed Yousef Tantash                                                        1.002%

 

·       Ms Maha Hamza Ahmed Yousef Tantash                                                          1.000%

 

·       Ms Basma Hamza Ahmed Yousef Tantash                                                        1.000%

 

·       Ms Rima Hamza Ahmed Yousef Tantash                                                          1.000%

 

·       Jordanian businessmen & private investors                                                      17.041%

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of gelatine capsules, pharmaceuticals, medicines and veterinary drugs.

 

Production Capacity: ACPC presently produces 1.7 billion capsules per year

 

Import Countries: Japan and Brazil

 

Export Countries: Iraq, Syria, Palestine, Saudi Arabia, Yemen & Egypt

 

Operating Trend: Steady

 

Subject has a workforce of approximately 120 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Jordanian Dinar (JD)

 

Balance Sheet                                                                             2010                            2009

 

Assets

Non-current assets

Property, plant & equipment, net                                                 1,799,415                      1,981,708

Investment accounted for using the equity method                        2,545,969                      2,486,705

Available for sale securities                                                                     1                                  1

Total non-current assets                                                          4,345,385                      4,468,414

 

Current assets

Inventory                                                                                      132,679                         121,471

Other current assets                                                                     935,302                         218,442

Due from related parties                                                              1,780,663                      1,308,510

Accounts receivable, net                                                    670,154                         418,528

Trading securities                                                                          371,062                         471,590

Checks under collection                                                                  29,691                          11,925

Cash and cash equivalents                                                           194,489                         792,576

Total current assets                                                                 4,114,040                      3,343,042

 

Total Assets                                                                             8,459,425                      7,811,456

 

Equity

Authorized and paid in capital                                                     5,000,000                      5,000,000

Issuance premium                                                                      3,000,000                      3,000,000

Statutory reserve                                                                        1,138,105                      1,126,511

Voluntary reserve                                                                          701,989                         796,348

Retained earnings                                                                           81,416                        155,641

Total equity                                                                             7,221,510                      7,378,500

 

Non-current liabilities

Bank facilities – long term                                                              513,050                             -

 

Current liabilities

Bank facilities – short term                                                            262,720                             -

Accounts payable                                                                           85,491                          81,330

Shareholders withholdings                                                             229,439                         153,883

Other current liabilities                                                                   147,215                         197,743

Total current liabilities                                                                           724,865                         432,956

Total Liabilities                                                                        1,237,915                         432,956

 

Total Equity and Liabilities                                                      8,459,425                      7,811,456

 

 

Income Statement                                                                       2010                            2009

 

Sales                                                                                        1,282,390                      1,813,700

Cost of sales                                                                             (1,112,557)                    (1,162,303)

Gross Profit                                                                                  169,833                         651,397

Selling and distribution expenses                                                  (104,063)                       (203,499)

General and administrative expenses                                             (264,382)                       (243,007)

Realized losses from selling trading securities                                 137,207                          (80,260)

Fair value adjustments                                                                      (2,647)                        (22,812)

Share of profit of equity accounted investment                                   54,254                          73,507

Provision for doubtful accounts                                                            -                               (65,000)

Finance expenses                                                                          (15,128)                            (129)

Other revenues                                                                             140,861                         186,027

Other fees and expenses                                                                (10,205)                        (25,521)

Income before tax                                                                         105,730                         270,703

Income tax provision                                                                       (12,720)                        (28,086)

Total comprehensive income for the year                               93,010                        242,617

 

 

Local sources consider subject’s financial condition to be Fair.

 

 




BANKERS

 

·       Arab Bank Plc

Shmeisani Branch

PO Box: 950545 & 950544

Amman 11195

Tel: (962-6) 5607231 / 5607115

Fax: (962-6) 5606793 / 5606830

 

·       Jordan Islamic Bank

Shmeisani Branch

PO Box: 926225

Amman 11195

Tel: (962-6) 5677377

Fax: (962-6) 5666326

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

Established in 1983, subject is involved in the manufacture of gelatine capsules, pharmaceuticals, medicines and veterinary drugs.

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk.

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.61

UK Pound

1

Rs.75.32

Euro

1

Rs.65.68

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.